Skip to main content

Advertisement

Advertisement

ADVERTISEMENT

June 2021

Featured Article

Research Reports
06/21/2021
Anne Runyan, BA
Daniele Severi-Bruni, MS
Kolajo Salako, BS
Oliver Walker, PhD
Anne Runyan, BA , and colleagues point out that, despite increasing cancer costs in the United States, payers’ willingness and ability to manage oncology drugs remains limited.
Anne Runyan, BA , and colleagues point out that, despite increasing cancer costs in the United States, payers’ willingness and ability to manage oncology drugs remains limited.
Anne Runyan, BA , and colleagues...
06/21/2021
Journal of Clinical Pathways

Column

Trending From ACCC
06/22/2021
J Clin Pathways. 2021;7(5):24-25. In 2016, the Association of Community Cancer Centers (ACCC) embarked on a 3-year, multiphase initiative to design, test, and refine an Optimal Care Coordination Model (the Model) for Medicaid patients...
J Clin Pathways. 2021;7(5):24-25. In 2016, the Association of Community Cancer Centers (ACCC) embarked on a 3-year, multiphase initiative to design, test, and refine an Optimal Care Coordination Model (the Model) for Medicaid patients...
J Clin Pathways....
06/22/2021
Journal of Clinical Pathways
COA Viewpoint
06/22/2021
Mark Thompson, MD, medical director of public policy, Community Oncology Alliance
Mark Thompson, MD, discusses drug pricing reform under the Biden administration.
Mark Thompson, MD, discusses drug pricing reform under the Biden administration.
Mark Thompson, MD, discusses...
06/22/2021
Journal of Clinical Pathways
Editor's Page
06/22/2021
Winston Wong, PharmD
Winston Wong, PharmD, discusses the articles in this issue, which include research on new payment models and payer management tools, and results from a study on the effectiveness of eribulin in subgroups of metastatic breast cancer patients...
Winston Wong, PharmD, discusses the articles in this issue, which include research on new payment models and payer management tools, and results from a study on the effectiveness of eribulin in subgroups of metastatic breast cancer patients...
Winston Wong, PharmD, discusses...
06/22/2021
Journal of Clinical Pathways
Pharma Insights
06/21/2021
Maureen Hennessey, PhD, CPCC, CPHQ
Elizabeth Oyekan, PharmD, FCSHP, CPHQ
Maureen Hennessey, PhD, CPCC, CPHQ, discusses Medicare spending as well as other performance measures related to the patient experience, management of depression and pain, emergency department and hospital use, end-of-life care, and...
Maureen Hennessey, PhD, CPCC, CPHQ, discusses Medicare spending as well as other performance measures related to the patient experience, management of depression and pain, emergency department and hospital use, end-of-life care, and...
Maureen Hennessey, PhD, CPCC,...
06/21/2021
Journal of Clinical Pathways

Department

Research in Review
06/21/2021
JCP Editors
J Clin Pathways. 2021;7(5):16-17. Real-World Health Care Utilization and Costs in the Huntsman at Home Program A recent study found that an oncology hospital at home program model may lower unplanned health care utilization and health...
J Clin Pathways. 2021;7(5):16-17. Real-World Health Care Utilization and Costs in the Huntsman at Home Program A recent study found that an oncology hospital at home program model may lower unplanned health care utilization and health...
J Clin Pathways....
06/21/2021
Journal of Clinical Pathways

Feature

Research Reports
06/21/2021
Sarah S Mougalian, MD
Jingchuan Zhang, PhD
Talia Miller, MSW, MPH
Marjorie E Zettler, PhD, MPH
Bruce A Feinberg, DO
A retrospective real-world study demonstrates the clinical effectiveness of eribulin in subgroups of MBC patients with poor prognostic characteristics, when used in accordance with the approved US indication.
A retrospective real-world study demonstrates the clinical effectiveness of eribulin in subgroups of MBC patients with poor prognostic characteristics, when used in accordance with the approved US indication.
A retrospective real-world study...
06/21/2021
Journal of Clinical Pathways

Advertisement

Advertisement

Advertisement